MHLW Drafts GCP Guidance To Strengthen Human Subject Protections For Device Trials
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japan's Ministry of Health, Labor and Welfare Nov. 11 posted a draft ministry ordinance on good clinical practices that would strengthen the country's human subject protections for participants in clinical device trials. The measure calls for independent institutional review boards to approve device trials
You may also be interested in...
Japan's MHLW Will Triple Review Officers To Shorten Device Lag
TOKYO - Responding to foreign criticisms about a long medical device approval lag, Japan's Ministry of Health, Labor and Welfare will implement several measures, including tripling the number of examination officers beginning in fiscal 2009 (which begins next April), as part of a new medical examination acceleration action program, a ministry official said Dec. 16
Japan's MHLW Will Triple Review Officers To Shorten Device Lag
TOKYO - Responding to foreign criticisms about a long medical device approval lag, Japan's Ministry of Health, Labor and Welfare will implement several measures, including tripling the number of examination officers beginning in fiscal 2009 (which begins next April), as part of a new medical examination acceleration action program, a ministry official said Dec. 16
Japan's MHLW Panel Awards Orphan Status To Century Medical Artificial Heart, Panasonic PDT Semiconductor Laser
TOKYO - Japan's Pharmaceutical and Food Sanitation Council's subcommittee on medical devices and in vitro diagnostics has approved two devices for orphan diseases and three others, Takeshi Baba, manager of the General Affairs Division of the Ministry of Health, Labor and Welfare's Pharmaceutical and Food Bureau told PharmAsia News Dec. 12